Digoxin Online

How and where to order Digoxin (Lanoxin) 0.25 mg tablets or capsules online on Tasmanian Air Rescue Trust website:

Prices:from $0.32 per pill
Discount:10% coupon: DFHDCC
Forms:Digoxin tablets 0.25 mg, Lanoxin tablets 0.25 mg
Quantity:30-360 pills
Type:Digoxin brand, Lanoxin generic
Payment:Visa, Mastercard, AmEx, E-Check (ACH), Bitcoin
Delivery:Regular and express mail service
Shipping:Worldwide, including USA, UK, Europe, Canada, Australia

Digoxin (trade names include Lanoxin, Cardoxin, Digitek, Digoxin Sandoz, Digoxin Teva, Digoxin Semi, Digoxine Nativelle, Lanicor, Lanox, Lanoxicaps, Lanoxin-PG, Pediatric Digoxin, Sigmaxin, Toloxin) is a medication for cardiovascular system from digitalis glycosides pharmacological group. This medicine is widely indicated for the treatment of various heart conditions such as chronic heart failure, congestive heart failure, atrial fibrillation, atrial flutter (irregular heartbeat), other heart rhythm disorders. It is also used as a feticidal agent during abortions. Lanoxin helps to control the symptoms of tiredness, breathlessness and fluid retention. Digoxin works by slowing down the rate of the heart so that each heartbeat is more effective at pumping blood.

Lanoxin (Digoxin) 0.25 mg tablets

Related medications:

  • Acetyldigitoxin (Acylanid)
  • Acetyldigoxin (Sandolanid)
  • Amiloride, Hydrochlorothiazide (Moduretic)
  • Amlodipine (Norvasc)
  • Atenolol (Tenormin)
  • Captopril (Capace)
  • Deslanoside (Cedilanide)
  • Digitoxin (Digitaline)
  • Doxazosin (Cardura)
  • Enalapril (Vasotec)
  • Enalapril, Hydrochlorothiazide (Vaseretic)
  • Gitoformate (Dynocard)
  • Lanatoside C (Celanide)
  • Lisinopril (Prinivil)
  • Losartan (Cozaar)
  • Methylprednisolone (Medrol)
  • Metildigoxin (Lanitop)
  • Nimodipine (Nimotop)
  • Perindopril (Aceon)
  • Propranolol (Inderal)
  • Ramipril (Altace)
  • Ticlopidine (Ticlid)
  • Verapamil (Calan)

    Pharmacological and medical categories:

  • Cardio glycosides
  • Cardiotonic agents
  • Medication for the treatment of various heart conditions
  • Medicines to treat irregular heart beat
  • Gynecological drugs

    ATC codes:

  • C - Cardiovascular system
  • C01 - Cardiac therapy
  • C01A - Cardiac glycosides
  • C01AA - Digitalis glycosides
  • C01AA05 - Digoxin

    ICD-10 codes:

  • Paroxysmal tachycardia - I47
  • Atrial fibrillation and flutter - I48
  • Heart failure - I50
  • Encounter for elective termination of pregnancy - Z33.2

    Indications and usage:

    Lanoxin (Digoxin) is a cardiac glycoside indicated for:

  • Treatment of mild to moderate heart failure in adults.
  • Increasing myocardial contractility in pediatric patients with heart failure.
  • Control of resting ventricular rate in patients with chronic atrial fibrillation in adults.

    Dosage and administration:

    Lanoxin tablets dose is based on patient-specific factors (age, lean body weight, renal function, etc.). See full prescribing information. Monitor for toxicity and therapeutic effect.

    Dosage forms and strengt:

  • Lanoxin (Digoxin) unscored tablets: 62.5 and 187.5 mcg.
  • Lanoxin (Digoxin) scored tablets 125 and 250 mcg.


    Signs and symptoms in adults and children

    The signs and symptoms of toxicity of are generally similar to those described in the adverse reactions but may be more frequent and can be more severe. Signs and symptoms of digoxin toxicity become more frequent with levels above 2 ng/mL. However, in deciding whether a patient's symptoms are due to digoxin, the clinical state together with serum electrolyte levels and thyroid function are important factors.


    Chronic overdose

    If there is suspicion of toxicity, discontinue Lanoxin and place the patient on a cardiac monitor. Correct factors such as electrolyte abnormalities, thyroid dysfunction, and concomitant medications. Correct hypokalemia by administering potassium so that serum potassium is maintained between 4.0 and 5.5 mmol/L. Potassium is usually administered orally, but when correction of the arrhythmia is urgent and serum potassium concentration is low, potassium may be administered by the intravenous route. Monitor electrocardiogram for any evidence of potassium toxicity (e.g., peaking of T waves) and to observe the effect on the arrhythmia. Avoid potassium salts in patients with bradycardia or heart block. Symptomatic arrhythmias may be treated with Digoxin Immune Fab.

    Acute overdose

    Patients who have intentionally or accidently ingested massive doses of digoxin should receive activated charcoal orally or by nasogastric tube regardless of the time since ingestion since digoxin recirculates to the intestine by enterohepatic circulation. In addition to cardiac monitoring, temporarily discontinue Digoxin (Lanoxin) until the adverse reaction resolves. Correct factors that may be contributing to the adverse reactions. In particular, correct hypokalemia and hypomagnesemia. Digoxin is not effectively removed from the body by dialysis because of its large extravascular volume of distribution. Life threatening arrhythmias (ventricular tachycardia, ventricular fibrillation, high degree A-V block, bradyarrhythma, sinus arrest) or hyperkalemia requires administration of Digoxin Immune Fab. Digoxin Immune Fab has been shown to be 80-90% effective in reversing signs and symptoms of digoxin toxicity. Bradycardia and heart block caused by digoxin are parasympathetically mediated and respond to atropine. A temporary cardiac pacemaker may also be used. Ventricular arrhythmias may respond to lidocaine or phenytoin. When a large amount of digoxin has been ingested, especially in patients with impaired renal function, hyperkalemia may be present due to release of potassium from skeletal muscle. In this case, treatment with Digoxin Immune Fab is indicated; an initial treatment with glucose and insulin may be needed if the hyperkalemia is life-threatening. Once the adverse reaction has resolved, therapy with Lanoxin may be reinstituted following a careful reassessment of dose.


  • Ventricular fibrillation.
  • Known hypersensitivity to digoxin or other forms of digitalis.

    Warnings and precautions:

  • Risk of rapid ventricular response leading to ventricular fibrillation in patients with AV accessory pathway.
  • Risk of advanced or complete heart block in patients with sinus node disease and AV block.
  • Digoxin toxicity: indicated by nausea, vomiting, visual disturbances, and cardiac arrhythmias. Advanced age, low body weight, impaired renal function and electrolyte abnormalities predispose to toxicity.
  • Risk of ventricular arrhythmias during electrical cardioversion.
  • Not recommended in patients with acute myocardial infarction.
  • Avoid Digoxin (Lanoxin) in patients with myocarditis.

    Adverse reactions, side effects:

    The overall incidence of adverse reactions with digoxin has been reported as 5-20%, with 15-20% of adverse events considered serious. Cardiac toxicity accounts for about one-half, gastrointestinal disturbances for about one-fourth, and CNS and other toxicity for about one-fourth of these adverse events.

    To report suspected side effects of Lanoxin (Digoxin) tablets contact GlaxoSmithKline pharmaceutical company, or your local FDA.

    Drug interactions:

  • PGP inducers/inhibitors: drugs that induce or inhibit PGP have the potential to alter digoxin pharmacokinetics.
  • The potential for drug-drug interactions must be considered prior to and during drug therapy.

    Use in specific populations:

  • Pregnant patients: it is unknown whether use during pregnancy can cause fetal harm.
  • Pediatric patients: newborn infants display variability in tolerance to digoxin tablets.
  • Geriatric patients: consider renal function in dosage selection, and carefully monitor for side effects.
  • Renal impairment: Lanoxin is excreted by the kidneys. Consider renal function during dosage selection.

    Patient counseling information:

  • Advise patients that digoxin is used to treat heart failure and heart arrhythmias.
  • Instruct patients to take this medication as directed.
  • Advise patients that many drugs can interact with Lanoxin. Instruct patients to inform their doctor and pharmacist if they are taking any over the counter medications, including herbal medication, or are started on a new prescription.
  • Advise patient that blood tests will be necessary to ensure that their digoxin dose is appropriate for them.
  • Advise patients to contact their doctor or a health care professional if they experience nausea, vomiting, persistent diarrhea, confusion, weakness, or visual disturbances (including blurred vision, green-yellow color disturbances, halo effect) as these could be signs that the dose of Lanoxin may be too high.
  • Advise parents or caregivers that the symptoms of having too high Lanoxin (Digoxin) tablets doses may be difficult to recognize in infants and pediatric patients. Symptoms such as weight loss, failure to thrive in infants, abdominal pain, and behavioral disturbances may be indications of digoxin toxicity.
  • Instruct the patient to monitor and record their heart rate and blood pressure daily.
  • Instruct women of childbearing potential who become or are planning to become pregnant to consult a physician prior to initiation or continuing therapy with Lanoxin pills.

    Pregnancy categories:

  • A - Australia
  • C - United States (Risk cannot be ruled out)

    Salts and other forms:

  • Digoxin Base
  • Digoxin Andydrous

    Synonyms, international and chemical names:

  • Digitalique
  • Digitalis
  • Digoksiin
  • Digoksiini
  • Digoksin
  • Digoksyna
  • Digossina
  • Digoxigenin Tridigitoxosid
  • Digoxina
  • Digoxine
  • Digoxinis
  • Digoxinum

    Brands, generics, trade names:

  • Cardioxin - Novartis, Oboi Laboratories, Phil Pharmawealth
  • Cardoxin - Evsco Pharmaceutical
  • Digitek - Mylan, Global Pharmaceuticals
  • Digobal - Baldacci Farmoquimica
  • Digoregen - R.A.N. Novesia Arzneimittel
  • Digossina - Fisiopharma
  • Digoxin - Actavis, Agencia Lei Va Hong, Zuellig Pharma, Aspen, Baxter, GlaxoSmithKline, Mylan, Novartis, Roxane Laboratories, Sandoz, Teva, Zentiva
  • Digoxin Mite - Orion Pharma
  • Digoxin Pediatric - Hospira
  • Digoxin Semi - Orion Pharma
  • Digoxina - Chile Laboratorios, Cipla, GlaxoSmithKline, Kern Pharma, Novartis, Teofarma
  • Digoxine - Biologici Italia Laboratories, Kombivet, Sandoz
  • Digoxine Nativelle - Procter & Gamble, Galien Laboratoire, Teofarma
  • Eudigox - Teofarma
  • Fargoxin - Fahrenheit, Pratapa Nirmala
  • Hemigoxine Nativelle - Procter & Gamble, Teofarma
  • Lanacordin Pediatrico - Kern Pharma
  • Lanacrist - AstraZeneca
  • Lanibos - Bosnalijek Pharmaceuticals
  • Lanicor - Roche
  • Lanox - Gland Pharma, International Apex Pharmaceuticals
  • Lanoxicaps - GlaxoSmithKline, Cardinal Health
  • Lanoxin - GlaxoSmithKline
  • Lanoxin Mite - GlaxoSmithKline, Aspen
  • Lanoxin Pediatric - GlaxoSmithKline, Covis Pharmaceuticals, DSM Pharmaceuticals, Pharmascience, Virco Pharmaceuticals
  • Lanoxin-PG - GlaxoSmithKline, Aspen
  • Lenoxin - GlaxoSmithKline
  • Pediatric Digoxin - Sandoz, Sabex
  • Purgoxin - Aspen, Pharmacare
  • Sigmaxin - Sigma Pharmaceuticals
  • Toloxin - MM Therapeutics, Pendopharm
  • Valvulan - Armstrong Laboratorios de Mexico
  • Vidaxil - Victory Enterprises

    APIs used in medicine in combinations with digoxin:

  • Ajmaline
  • Alcohol (Ethanol)
  • Antazoline
  • Bencyclane
  • Carbocromen
  • Cinnarizine
  • Crataegus
  • Dyphylline
  • Etamivan
  • Etofylline
  • Hexobendine
  • Magnesium Aspartate
  • Magnesium Dehydrocholate
  • Magnesium Nicotinate
  • Naftidrofuryl Oxalate
  • Nitroglycerin
  • Oxyfedrine
  • Pentifylline
  • Phenobarbital
  • Potassium Aspartate
  • Proxyphylline
  • Raubasine
  • Sodium Fluoride
  • Sparteine Sulfate
  • Theobromine
  • Theophylline
  • Trimetozine
  • Verapamil
  • Vitamin B1 (Thiamine Hydrochloride)
  • Vitamin B3 (Nicotinic Acid)
  • Vitamin D3 (Cholecalciferol)

    Here is a list of popular medications containing digoxin as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

    Trade name of the drug Pharmaceutical forms and doses Companies
  • Tablets; Oral; Digoxin 0.125 mg
  • Tablets; Oral; Digoxin 0.25 mg
  • Mylan
  • Global Pharmaceuticals
  • Digoxin
  • Injectable; Injection; Digoxin 0.25 mg / ml
  • Tablets; Oral; Digoxin 0.125 mg
  • Tablets; Oral; Digoxin 0.25 mg
  • Sandoz
  • Lanicor
  • Drops; Oral; Digoxin 0.75 mg / ml
  • Injectable; Injection; Digoxin 0.25 mg / ml
  • Tablets; Oral; Digoxin 0.25 mg
  • Roche
  • HLB Pharma
  • Pliva
  • Teofarma
  • Vargas Laboratorios
  • Lanox
  • Injectable; Infusion; Digoxin 0.25 mg / ml
  • Gland Pharma
  • International Apex Pharmaceuticals
  • Lanoxin
  • Drops; Oral; Digoxin 0.05 mg / ml
  • Elixir; Oral; Digoxin 0.25 mg / 5 ml
  • Injectable; Injection; Digoxin 0.25 mg / ml
  • Tablets; Oral; Digoxin 0.0625 mg
  • Tablets; Oral; Digoxin 0.125 mg
  • Tablets; Oral; Digoxin 0.1875 mg
  • Tablets; Oral; Digoxin 0.25 mg
  • Tablets; Oral; Digoxin 0.375 mg
  • Tablets; Oral; Digoxin 0.5 mg
  • GlaxoSmithKline
  • Aspen
  • B & S Healthcare
  • Concordia Pharmaceuticals
  • Covis Pharmaceuticals
  • DSM Pharmaceuticals
  • Eureco-Pharma
  • Invida
  • Medac
  • Menarini
  • Orion Pharma
  • P & D Pharmaceuticals
  • Pharmacare
  • Pharmascience
  • Roemmers Laboratorios
  • S & M Medical
  • Sigma Pharmaceuticals
  • Virco Pharmaceuticals
  • Wael Pharmacy
  • Zuellig Pharma
  • Lanoxin-PG
  • Injectable; Injection; Digoxin 0.05 mg / ml
  • Tablets; Oral; Digoxin 0.0625 mg
  • GlaxoSmithKline
  • Aspen
  • Central Procurement & Supplies Unit
  • Invida
  • Menarini
  • O.P.D. Laboratories
  • P & D Pharmaceuticals
  • Servipharm
  • Star Pharmaceuticals
  • Zuellig Pharma
  • Sigmaxin
  • Tablets; Oral; Digoxin 0.0625 mg
  • Tablets; Oral; Digoxin 0.25 mg
  • Sigma Pharmaceuticals
  • Aspen
  • Fawns & McAllan
  • Toloxin
  • Solution; Oral; Digoxin 0.05 mg / ml
  • Tablets; Oral; Digoxin 0.0625 mg
  • Tablets; Oral; Digoxin 0.125 mg
  • Tablets; Oral; Digoxin 0.25 mg
  • MM Therapeutics
  • Pendopharm
  • T.O. Chemicals

  • References:

  • Digoxin main article on Wikipedia: https://en.wikipedia.org/wiki/Digoxin
  • Digoxin compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Digoxin
  • Digoxin medicine on DrugBank: https://go.drugbank.com/drugs/DB00390
  • Digoxin and derivatives group on DrugBank: https://go.drugbank.com/categories/DBCAT003177
  • Digoxin FAQ on MedlinePlus (revised 06/15/2017): https://medlineplus.gov/druginfo/meds/a682301.html
  • Digoxin Hikma tablets drug label info on DailyMed (revised June 19, 2020): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
  • Lanoxin (Digoxin) tablets drug label info on DailyMed (revised August 18, 2020): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
  • Digitek (Digoxin) tablets drug label info on DailyMed (revised February 15, 2019): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
  • Digoxin containing drugs on Drugs-About.com: https://drugs-about.com/ing/digoxin.html
  • Digoxin for sale on Pharma Doctor: https://pharma-doctor.com/digoxin.html
  • Lanoxin (Digoxin) tablets for oral use official prescribing information from the U.S. FDA (revised 12/2016): https://www.accessdata.fda.gov/drugsatfda_docs/label...
  • Lanoxin (Digoxin) tablets prescribing information from GlaxoSmithKline pharmaceutical company (revised 28 October 2020): https://india-pharma.gsk.com/media/701249/lanoxin-tablets.pdf
  • Lanoxin (Digoxin) tablets professional and consumer information from RxList (revised 04/14/2021): https://www.rxlist.com/lanoxin-tablets-drug/patient-images-side-effects.htm
  • Sigmaxin (Digoxin) tablets product information from The Therapeutic Goods Administration (revised 05 August 2020): https://www.ebs.tga.gov.au/ebs/picmi/...
  • Lanoxin (Digoxin) 0.25 mg tablets patient information leaflet from Medicines.org.uk (revised December 2019): https://www.medicines.org.uk/emc/files/pil.5465.pdf
  • Digoxin Accord 0.0625 mg, 0.125 mg, 0.25 mg tablets patient information leaflet from Medicines.org.uk (revised January 2021): https://www.medicines.org.uk/emc/files/pil.5772.pdf

    Revised: July 2021

    Home | About Us | Our Aims | The Crew | Aircraft | Sponsors | News | Contact Details

    Copyright © 2001 - 2021 Tasmanian Air Rescue Trust - Westpac Rescue Helicopter Service. All rights reserved.